News

All Updates


Jun 24, 2024
Press Release

E&C Republicans Press FDA Again for Information Regarding Foreign Inspection Program

Washington, D.C. — In a new letter to Food and Drug Administration (FDA) Commissioner Robert Califf, House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA), Subcommittee on Health Chair Brett Guthrie (R-KY), and Subcommittee on Oversight and Investigations Chair Morgan Griffith (R-VA) are pressing for more information regarding the agency’s foreign drug inspection program. The letter continues the Committee’s investigation into FDA inspection practices, which include a July 18, 2023, letter , a December 13, 2023, letter , and a February 6, 2024, oversight hearing at which the FDA declined to make an official available to testify.  BACKGROUND :  In the letter, the Members discuss the Committee’s analysis of FDA inspection outcomes in India and China from January 2014 to April 2024, limiting its review to inspectors with ten or more inspections in either China or India.   EXCERPT OF THE ANALYSIS :  “The results of this analysis were surprising, revealing tremendous variation in inspection outcomes. Some FDA inspectors found compliance issues during all or almost all of their inspections. Other inspectors rarely reported finding a single compliance issue. Two inspectors never found a single compliance issue over the course of a combined 24 inspections in India. Another inspector found zero compliance issues in 20 out of 23 inspections (85 percent) in China while finding compliance issues with almost half of domestic inspections during the same period. These are unusual inspection outcomes, the opposite of what would be expected given the widely reported failures in quality control and lack of adherence to current good manufacturing techniques by drug manufacturing facilities in China and India.  “By contrast, 16 FDA inspectors, with over 325 inspections collectively in India, found compliance issues during every inspection they conducted. As a measure of what a pattern of rigorous inspections should look like, the Committee reviewed the inspection outcomes for 3 FDA inspectors with professional reputations for thoroughness who also had at least 10 inspections in China or India during the studied time period. These expert inspectors reported finding no compliance issues during inspections in China at a rate of only 6.7 to 11.4 percent and at a rate of zero to 9.5 percent in India.”  KEY LETTER EXCERPT : “Such large variations in inspection outcomes are troubling, and they merit further investigation. At a minimum, the Committee is concerned that these findings suggest vast differences in the skill, thoroughness, and competence of FDA inspectors. The difference in inspection outcomes appears to be just another example of institutional weaknesses and dysfunction in the FDA’s foreign drug inspection program. Prior to the pandemic, media reporting found that some FDA inspectors took an inappropriately lenient approach with foreign drug manufacturers with serious compliance violations. There were also reports o f, and concerns about, foreign manufacturers attempting to bribe or improperly influence inspectors. The Committee is seriously evaluating the disturbing possibility that some of the variation in inspection outcomes could be the result of bribery or fraud.”  CLICK HERE to read the full letter. 



Jun 24, 2024
Blog

Five Ways Your Data is Used to Surveil and Manipulate You

Big Tech is tracking your every move. From your conversations with friends and family that you thought were private, to your online searches across the internet and shopping history, and even your current location. Many of these companies are monetizing that data and weaponizing it to erode your agency, your rights, and your identity. Below are five ways Big Tech, data brokers, and other bad actors in the information ecosystem are collecting and exploiting your personal information: “A six-year span of internal Google reports, unearthed by 404 Media, exposes a troubling array of privacy breaches affecting everything from children's voice data to the home addresses of unsuspecting carpool users.”  […]  “This internal database, not previously exposed to the public eye, catalogs various incidents ranging from trivial mishaps—like an inadvertently sent email containing sensitive personal information—to major security lapses, including significant data leaks and even potential raids on Google’s own offices.”  […]  “This breach, which left sensitive data like geolocation information and IP addresses accessible via the platform’s page source, lingered undetected for more than a year, affecting numerous users, including children.” “Almost no one was surprised that Google Maps accessed location information, for example, but respondents had a strong negative reaction when they learned that the “Brightest Flashlight” app tracked their location, said Jason Hong, an associate professor at school.” […] “Of the top 100 Android apps, 56 collected location information, device identifiers and/or contact lists, according to the university’s research. Users, however, often had no idea such data was being collected or how it might be used.” “Every minute of every day, everywhere on the planet, dozens of companies—largely unregulated, little scrutinized—are logging the movements of tens of millions of people with mobile phones and storing the information in gigantic data files." […]  “If you could see the full trove, you might never use your phone the same way again." […]  “You’ve probably never heard of most of the companies—and yet to anyone who has access to this data, your life is an open book. ”  […]  “… this file represents just a small slice of what’s collected and sold every day by the location tracking industry— surveillance so omnipresent in our digital lives that it now seems impossible for anyone to avoid.”  […]  “Within America’s own representative democracy, citizens would surely rise up in outrage if the government attempted to mandate that every person above the age of 12 carry a tracking device that revealed their location 24 hours a day .”  […]  “Now, as the decade ends, tens of millions of Americans, including many children, find themselves carrying spies in their pockets during the day and leaving them beside their beds at night — even though the corporations that control their data are far less accountable than the government would be.”  […]  “In absence of a federal privacy law, the industry has largely relied on self-regulation.” “Facebook, for example, collects location-related information aside from your phone’s GPS. It still tracks where you are through IP addresses, ‘check-ins or events you attend.  “Twitter also ‘requires’ information about your current location, ‘which we get from signals such as your IP address or device settings.’ This is so it can ‘securely and reliably set up and maintain your account.’” […]  “… the data that dating app Tinder collects is shared with other members of the Match Group…”  […]  “Facebook even tracks what you do when you’re not signed into it – or when you don’t have an account.” “You know you have a credit score. Did you know that you might also have a driving score?”  […]  “‘ No one who realizes what they’re doing would consent ,’ said Kathleen Lomax, a New Jersey mother who recently canceled her subscription to Life360 when she found out this was happening.”  […]  “Insurers are also getting driving data directly from people’s cars.”  […]  “But any car with an internet connection, which most modern cars have, can send data back to the automaker.” The American Privacy Rights Act is Here to Help Most people are unaware about what happens with the data that is collected from them. Americans don’t trust Big Tech and other companies that are exploiting their personal data to target and manipulate people. The American Privacy Rights Act (APRA) is needed to give Americans a unified set of privacy rights.  The House Committee on Energy and Commerce, led by Chair Cathy McMorris Rodgers (R-WA), is fighting to ensure that Americans are protected from exploitation, including from Big Tech, data brokers, and other bad actors in the big data business. APRA creates a comprehensive, national data privacy standard to ensure that all Americans are protected.   APRA puts all Americans back in control of their personal data, protecting them and their kids. By minimizing the amount of data that can be collected, processed, retained, and transferred, Americans will have the right to control where their personal information goes and can ensure that Big Tech, data brokers, and other bad actors are held accountable. 



Jun 18, 2024
Press Release

Chairs Rodgers and Griffith Announce O&I Subcommittee Hearing on Anti-Doping Measures Ahead of the 2024 Olympics

Former Olympians Michael Phelps & Allison Schmitt scheduled to testify Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee on Oversight and Investigations Chair Morgan Griffith (R-VA) announced a hearing titled “Examining Anti-Doping Measures in Advance of the 2024 Olympics.” “Olympic athletes dedicate years of their lives to perfect their craft in order to represent the United States on the world stage. They—as well as athletes from every other country—deserve to compete on a level playing field that’s free of banned performance enhancing drugs,” said Chairs Rodgers and Griffith. “The World Anti-Doping Agency, the governing body responsible for enforcing fair standards, has a questionable track record of fulfilling that mission. This hearing will give Members a chance to examine that track record, identify opportunities for improvement, and ensure that the best athletes are the ones taking home gold medals.”  Subcommittee on Oversight and Investigations hearing titled “Examining Anti-Doping Measures in Advance of the 2024 Olympics.”   WHAT: A Subcommittee on Oversight and Investigations hearing to examine anti-doping measures ahead of the 2024 Olympics.  DATE: Tuesday, June 25, 2024  TIME: 7:00 PM ET  LOCATION: 2123 Rayburn House Office Building  CONFIRMED WITNESSES:    Mr. Michael Phelps, Former Olympic Athlete  Ms. Allison Schmitt, Former Olympic Athlete  Mr. Travis Tygart, Chief Executive Officer, U.S. Anti-Doping Agency  INVITED WITNESSES :  Mr. Witold Banka, President, World Anti-Doping Agency This notice is at the direction of the Chair. The hearing will be open to the public and press and will be live streamed online at https://energycommerce.house.gov/ . If you have any questions concerning the hearing, please contact Lauren Kennedy with the Committee staff at Lauren.Kennedy@mail.house.gov . If you have any press-related questions, please contact Christopher Krepich at Christopher.Krepich@mail.house.gov .  



Bipartisan E&C Leaders Applaud Passage of Historic Nuclear Energy Package

Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA), Full Committee Ranking Member Frank Pallone, Jr. (D-NJ), Energy, Climate, and Grid Security Subcommittee Chair Jeff Duncan (R-SC), and Subcommittee Ranking Member Diana DeGette (D-CO) released a joint statement today following the Senate’s passage of S. 870, which included a bipartisan, bicameral compromise of the Atomic Energy Advancement Act (H.R. 6544) and the Accelerating Deployment of Versatile, Advanced Nuclear for Clean Energy (ADVANCE) Act (S. 1111). “Energy is foundational to our way of life. In order to maintain our standard of living, support technological innovation, and cement America’s economic and national security for generations to come, we must be investing in safe, clean, and reliable sources of baseload power. This much needed modernization of our nuclear regulatory framework will help achieve this by enabling industry to deploy safe, reliable nuclear energy, leading to a new era of U.S. energy leadership. We are grateful to have worked alongside our Senate colleagues to pass this important legislation and look forward to President Biden signing it into law soon.”



Jun 18, 2024
Hearings

Chairs Rodgers and Bilirakis Announce Subcommittee Budget Hearing with Commerce Secretary Raimondo

Washington D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Innovation, Data, and Commerce Subcommittee Chair Gus Bilirakis (R-FL) announced a hearing titled “The Fiscal Year 2025 Department of Commerce Budget.”  “The Department of Commerce is tasked with ensuring American businesses have the resources they need to innovate, grow, and compete. In order to ensure the U.S. continues to be an economic and technological leader, we need sound, transparent policies that support American competitiveness, especially in emerging technologies,” said Chairs Rodgers and Bilirakis. “We look forward to our conversation with Secretary Raimondo to discuss how the Department of Commerce can further support American businesses and economic leadership.” Subcommittee on Innovation, Data, and Commerce hearing titled “The Fiscal Year 2025 Department of Commerce Budget.” WHAT: Subcommittee on Innovation, Data, and Commerce hearing to discuss President Biden’s FY 2025 budget request for the Department of Commerce.  DATE: Wednesday, June 26, 2024  TIME: 10:00 AM ET  LOCATION: 2123 Rayburn House Office Building  WITNESS: Hon. Gina Raimondo, Secretary, Department of Commerce This notice is at the direction of the Chair. The hearing will be open to the public and press and will be live streamed online at https://energycommerce.house.gov/ . If you have any questions concerning the hearing, please contact Alex Khlopin at Alex.Khlopin@mail.house.gov . If you have any press-related questions, please contact Sean Kelly at Sean.Kelly@mail.house.gov



Jun 14, 2024
Press Release

Chair Rodgers Unveils Framework for NIH Reform, Requests Stakeholder Input

Effort to begin conversation to revamp the public health agency, restore public trust Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) today unveiled a framework that lays out the current challenges facing the National Institutes of Health (NIH) and contains recommendations for reform. CLICK HERE to view the full framework. In a joint opinion piece with House Appropriations Subcommittee on Labor, Health and Human Services, and Education Chair Robert Aderholt (R-AL), Chair Rodgers makes the case for why reform is needed and asks for stakeholders to engage thoughtfully in the effort: "Let us be clear: We support the NIH and the critical role it plays in serving Americans, furthering scientific discovery, and ensuring the U.S. remains the world's leading pioneer in basic science and biomedical research innovation. But historical support for what an agency should or could be cannot prevent us from seeking to build upon past lessons or correct areas that have fallen short. "Our message to scientists, researchers, patient advocates, colleagues, and the American people is simple: Our door is open. Work with us. Be a partner. A deliberative, engaging process will lead to better outcomes for all. The framework being released today is just the start of a robust conversation, not a finished product. "The U.S. became a world leader in biomedical innovation because Americans are resourceful, resilient, and entrepreneurial. Let us continue to build on that legacy and work to ensure the NIH continues to deliver on the promises of hope for those in need." CLICK HERE to read the full opinion piece. CLICK HERE for a one-pager on the framework.  Stakeholders who wish to submit any feedback on the framework or provide additional thoughts, ideas, and suggestions for reform can do so by emailing NIHReform@mail.house.gov by August 16, 2024. The framework comes following the release of an interim staff report regarding the Committee’s ongoing investigation into a proposed MPXV project at the NIH, which uncovered a lack of oversight and transparency from the Department of Health and Human Services, the NIH, and the National Institute of Allergy and Infectious Diseases. KEY REPORT EXCERPT :  Ultimately, this investigation and interim report underscore the importance of restoring public trust in our government health agencies as well as Congress reasserting its Article I authority. Transparency and accountability are the most pressing remedies.  It also comes amid the Committee’s ongoing investigation into sexual harassment at the NIH and at NIH grantee institutions.  READ : August 10, 2021 : E&C Republican Leaders Question NIH’s Handling of Sexual Harassment Complaints     August 11, 2022 : E&C Republican Leaders follow up with NIH on Insufficient Response to its Letter on the NIH’s handling of Sexual Harassment     November 30, 2022 : E&C Republicans to NIH: Turn Over Previously Requested Information Ahead of New Congress     March 14, 2023 : E&C Republicans Press NIH for Information on Handling of Sexual Harassment Complaints     October 6, 2023 : E&C Republicans Signal Intent to Issue Subpoena to Obtain Information on NIH’s Handling of Sexual Harassment if Questions Go Unanswered     January 26, 2024 : Chair Rogers notifies NIH of Imminent Subpoena     February 5, 2024 : Chair Rodgers Subpoenas NIH for Documents Related to Investigation into Sexual Harassment at NIH and NIH Grantee Institutions    February 20, 2024 : HHS responds on behalf of NIH to offer a rolling in camera document review to the Committee. Documents produced in the review have been highly redacted, including the redaction of the names of individuals convicted of criminal offenses, public news articles about individuals who have been found guilty of harassment, and redaction of the names of the institutions where the abuse occurred—effectively preventing the Committee from understanding if NIH continues to fund work performed by substantiated abusers at other institutions—a practice known as “pass the harasser.”    April 16, 2024 : E&C Republicans Expand Investigation into Sexual Harassment at NIH to now Include Review of HHS Office of Civil Rights Compliance Role   May 9, 2024 : E&C Republicans ask Department of Health and Human Services (HHS) Secretary Xavier Becerra to provide the Committee with the legal basis requiring HHS to redact or hide the names of researchers determined to have committed sexual misconduct.  May 30, 2024 : Evidence Uncovered by E&C Republicans Refutes Secretary Becerra’s Assertion that HHS Takes Action to Prevent Sexual Abusers from Receiving Taxpayer Funding



Jun 13, 2024
Hearings

Chair Rodgers Opening Remarks at Hearing on CMS Innovation

Washington D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) delivered the following opening remarks at today’s Health Subcommittee hearing titled “Checking-In on CMMI: Assessing the Transition to Value-Based Care.” CMMI'S FAILURE TO LOWER COSTS    “The Center for Medicare and Medicaid Innovation was created to help improve how Medicare and Medicaid pay for health care and be an engine in our drive towards value-based care.   “CMMI was given a 10-year, $10 billion budget and extremely wide-ranging authorities with limited built-in congressional oversight.   “The only directives Congress gave CMMI were to achieve two goals: lower the cost of delivering care and improve patient outcomes.   “Over the last decade and a half, CMMI has tested over 50 models. Only two accomplished both of those goals.   “When CMMI was created, the savings it was projected to generate were to be used to offset spending by the Affordable Care Act.   “Originally, the Congressional Budget Office estimated that CMMI would save $1.3 billion over its first decade of operation.  “That same model also projected CMMI to save as much as $77.5 billion in its second decade, from 2020 to 2030.   “However, when CBO looked at the actual results in a September 2023 report, the disparity between those expectations and the reality proved to be staggering.   “Instead of reducing spending by $1.3 billion in the first decade, CMMI increased spending by $5.4 billion.   “For this second decade, instead of saving 77.5 billion dollars, CBO is now projecting CMMI to increase spending by $1.3 billion.   “I have a hard time believing any objective observer could look at the results thus far and describe CMMI as a success.   “So how do we move forward? “Today, we’re joined by Dr. Elizabeth Fowler, the current Director of CMMI, to discuss the Center’s work and understand why it has failed to live up to its intended purpose thus far. “I will note that Dr. Fowler has not been with CMMI throughout its entire existence. “In fact, CMMI has had multiple directors across multiple administrations. “But you are at the helm now and responsible for correcting this program’s trajectory, and while there are some reasons for optimism, a lot of what I have seen is concerning.” CMMI STRAYING FROM ITS CORE MISSION  “I’ve been disappointed to see CMMI devalue drugs approved through the FDA’s Accelerated Approval Pathway—which FDA leadership confirmed meet the agency’s gold-standard just a few weeks ago in this committee.   “This pathway was designed to build on precision medicine, encourage innovation, and allow patients to access needed cures sooner, but CMMI’s decision to cut reimbursements unilaterally for drugs approved via Accelerated Approval undercuts this mission.  “In addition, when Congress passed MACRA, thanks in large part to the work of this Committee, CMMI was given a cental role in driving Medicare’s transition to value-based care.   “While CMMI has developed and tested some new models, largely for primary care physicians, too many clinicians have been left without a pathway to participate in APMs.   “I’m concerned that instead of focusing on fulfilling the role Congress gave CMMI in MACRA and working on developing new APMs, CMMI’s focus has shifted to collecting information on patients' food insecurity and housing needs and requiring providers to waste time writing ridiculous 'health equity plans.’”  SOME POSITIVE OUTCOMES   “While I have concerns on the overall direction and lack of results with CMMI, there have been a few positive outcomes that deserve to be recognized.  “Looking at CMMI’s most recent work, I am glad you are continuing to build on the Accountable Care Organization model.   “While joining an ACO should not be the only pathway for providers to be able to participate in value-based care, these models are among the few that have actually managed to reduce overall spending and should not be abandoned.   “I was encouraged to see CMMI work on trying to improve care for Alzheimer’s and dementia patients.   “Sadly, most people know someone that has suffered from this terrible disease, and I hope that this model is successful in improving community-based care for those patients.   “Lowering the costs of health care in this country has been a primary mission of this Committee this Congress. We are on an unsustainable path and must continue to find ways to reverse the current trend. “This makes it all the more important that CMMI carries out its intended mission and avoids pursuing an alternative agenda. “Dr. Fowler, I am grateful you are here to share your expertise and eager to hear what lessons CMMI has learned and how we can get it back on track to lower costs and improve care.” 



Jun 13, 2024
Press Release

Subcommittee Chair Guthrie Opening Remarks at Hearing on CMS Innovation

Washington D.C. —  House Energy and Commerce Subcommittee on Health Chair Brett Guthrie (R-KY) delivered the following opening remarks at today’s subcommittee  hearing  titled “Checking-In on CMMI: Assessing the Transition to Value-Based Care.”  “Thank you to our witness, Dr. Liz Fowler, for being here with us today as we ‘check-in’ on the Centers for Medicare and Medicaid Innovation’s progress in lowering costs and improving quality of care paid for by Medicare and Medicaid. “Our health care system has underdone significant changes over the last decade and Americans continue to cite health care costs as a top concern. “More Americans are stuck paying more for health care, more than they ever have in the past.” HEALTH CARE EXPENDITURES RAPIDLY INCREASING ON THE BACKS OF TAXPAYERS AND PATIENTS “Taxpayers are also on the hook for higher health care expenditures. “In 2022, health care spending grew by 4% year-over-year, reaching $4.5 trillion, nearly 17% of U.S. gross domestic product. “During this same time, spending on hospital care reached 30% of total health care spending while physician and clinical services reached 20% of all health care spending.   “Physicians are now being forced to spend more man hours on back-office administrative tasks in efforts by taxpayers to keep costs low.” CMMI FAILED TO ACHIEVE PROJECTED COST SAVINGS “Policy makers and stakeholders from across the health care system have hoped that by embracing value-based care, high costs and physician burnout would be addressed, and patients would receive a higher quality of care.   “The Centers for Medicare and Medicaid Innovation was supposed to be a key driver of this movement toward value-based care.   “However, Medicare and Medicaid’s transition to value care has clearly stagnated.   “CMMI was established as a part of the Affordable Care Act with the dual goal of driving better patient outcomes and slowing the growth rate of the Medicare and Medicaid program costs.   “The Congressional Budget Office originally projected that CMMI would not just offset the costs of running pilot programs but drive significant long-term savings across our health care system.   “That unfortunately has not come close to materializing. A September 2023 CBO report found that CMMI’s activities increased spending by almost $5.5 billion.    “Under the Biden administration the Center has undertaken an internal reevaluation.   “While I would hope this strategic refresh would generate a renewed commitment to better fulfilling CMMI’s mission of reducing costs and improving quality in its second decade.   “However, I must admit I am concerned the Center has instead further shifted focus from its Congressionally anointed purpose.   “I would be remised if I didn’t mention a few specific actions CMMI has taken recently that could significantly harm the transition to value-based care.   “The first, is the so-called Accelerating Clinical Evidence model in which CMMI has proposed to slash payments to Part B providers who are prescribing therapies fully approved by the FDA through the Accelerated Approval Pathway.   “This not only undermines the FDA gold standard but penalizes those attempting to drive transformative change for patients that otherwise lack treatment options.”  CMMI IS IMPEDING INNOVATION “I am furthermore concerned about CMMI’s Cell and Gene Therapy Access Model, which may inhibit the states’ ability to use value-based agreements to pay for curative cell-and-gene therapies approved by FDA. “We have 50 incubators across the country in the form of our state Medicaid programs and waiver authorities that give states the ability to shape policies that make the most sense for their budgetary needs and the needs of their beneficiaries. “By CMS directly negotiating drug rates for these therapies, it weakens the ability for states to negotiate directly with manufacturers or to form states compacts that give states greater bargaining power in these situations. “I would instead urge CMMI and CMS to work with Congress to pass my MVP Act, which I’ve worked with Ranking Member Eshoo on, which would codify CMS’ multiple best price rule and truly allow states to use value-based agreements to get life-changing treatments to patients as quickly and as affordably as possible, should be the goal of all of us. “In closing, I hope today’s discussion helps us chart a path forward for CMMI that can ensure the center is better delivering on its mission to facilitate innovation payment models that deliver for patients and taxpayers and reenergize the transition to value-based care.” 



Jun 13, 2024
Blog

Consumer Groups, Venues, and Artists Applaud House Passage of the Ticket Act

Washington D.C. —  Consumer advocates and stakeholders agree that H.R. 3950, the  Transparency in Charges for Key Events Ticketing (TICKET) Act , will restore fairness and transparency to the ticketing marketplace. The bill, which  passed the House last month by a vote 388-24 , will significantly enhance the customer experience of buying event tickets online. This united message from stakeholders should send a clear message to the Senate that they must act quickly to pass this important legislation so it can be sent to President Joe Biden’s desk and signed into law. Ticket Buyer Bill of Rights “Congratulations to Representatives Bilirakis and Schakowsky for achieving this important milestone. Today marks the furthest federal live event ticketing reform has gone in nearly a decade. We applaud them for their leadership and their willingness to engage all stakeholders, especially consumer protection organizations, in seeking a truly comprehensive reform package which has consensus by virtually every stakeholder in the debate. We urge the Senate to send the  TICKET Act  to President Biden’s desk as expeditiously as possible.” National Consumers League “Fairness in live event ticketing took a huge step forward today,”  said John Breyault, Vice President of Public Policy, Telecommunications and Fraud at the National Consumers League.  “For decades, the simple act of buying a ticket to see your favorite artist or team has been an exercise in frustration. Thanks to leaders like Chairman Bilirakis and Ranking Member Schakowsky, the days that ticketing companies can get away with ridiculous ticket add-on fees and deceptive resale websites are numbered.” National Independent Venue Association “We commend House passage of H.R. 3950, the  TICKET Act , which will help to improve the ticket buying experience for fans, to protect the livelihoods of artists, and to preserve independent venues across the nation,"  said Stephen Parker, Executive Director of the National Independent Venue Association.  "Not only has the U.S. House of Representatives moved to protect consumers from predatory and deceptive ticketing practices, but states across the country, including Arizona, Maryland, Minnesota and Nevada, have recently banned, without exception, speculative tickets on a bipartisan basis. We call on Congress to do the same, to build on the  TICKET Act  and adopt strong, enforceable, comprehensive ticketing reform legislation like the Fans First Act.” Artist Rights Alliance “ARA applauds the House's passage of the  TICKET Act , a positive move towards increased transparency and fairness in ticketing. We will continue to advocate for a fair and equitable ticketing system that fully supports artists and fans.” Sports Fans Coalition “Today is a momentous day for live event ticketing reform,”  said Brian Hess, Executive Director of Sports Fans Coalition.  “If enacted, this bill will guarantee sports fans all-in pricing, prohibitions on several deceptive sales tactics, and refund requirements for canceled events. We hope the Senate will pass this vital legislation and that President Biden will sign it shortly thereafter.” Recording Academy "Today's passage of the  TICKET Act  by the House of Representatives marks a significant step forward toward improving the concert ticket marketplace,"  said Recording Academy CEO Harvey Mason Jr.  "The  TICKET Act  was a key focus of GRAMMYs on the Hill [...] and the Recording Academy thanks our Congressional leaders for bringing the bill to a vote shortly after meeting with Academy members.” – Recording Academy CEO Harvey Mason Jr. Live Nation (Ticketmaster) “Live Nation applauds House lawmakers for advancing the  TICKET Act . [...] We look forward to working with policymakers to make these changes law.” Coalition for Ticket Fairness "The Coalition for Ticket Fairness (CTF) applauds The House on the passage of The  TICKET Act . Introduced by Subcommittee on Innovation, Data, and Commerce Chair Gus Bilirakis and Ranking Member Jan Schakowsky, The  TICKET Act  represents common sense reforms that will bring much needed transparency into the ticket buying process and give consumers more information as they make purchasing decisions. By empowering consumers, this bill will help lead to a better ticket buying experience and a healthier marketplace. “CTF is proud to have been supportive of the  TICKET Act  from the beginning. We believe in leveling the playing field in the ticket marketplace and ensuring that fans have options. We encourage the Senate to move forward in passing their version of the bill as soon as possible." Fix the Tix Coalition “The Fix the Tix Coalition, representing every major constituency of the music and live events industry, applauds the passage of H.R. 3950, the  TICKET Act , as an important step towards restoring trust in the ticketing ecosystem. The bill provides transparency with all-in pricing, and takes important steps to combat speculative tickets and deceptive websites. [...] The live entertainment ecosystem is counting on Congress to act in the best interests of fans to restore transparency and trust to our country’s broken ticketing system.” Vivid Seats “Vivid Seats applauds Chairman Bilirakis, Congresswoman Schakowsky and the Committee Members for their hard work and dedication to legislation that will help fans across the country. We believe the  TICKET Act  will not only improve the process of purchasing tickets to live events, but its comprehensive approach will increase transparency that has been needed for decades.” NetChoice “Thank you to Rep. Bilirakis and Rep. Schakowsky for leading the House effort to get the  TICKET Act  passed! This pro-consumer legislation will bring much needed transparency to the tickets marketplace.” StubHub “StubHub applauds the House’s overwhelming support of the  TICKET Act  which protects consumers and preserves an innovative and competitive marketplace. It establishes a uniform national standard for all-in pricing for the entire live events industry, creating consistency and strong protections for fans across the US.”  Consumer Action “This bill lets fans know that when they buy a ticket to their favorite events, they’ll be assured that the ticket is real, the price is clear and a refund is available if the event is cancelled. That’s some real progress for consumers,”  said Ruth Susswein, Consumer Action’s Director of Consumer Protection.